PODD

Insulet Corporation · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website insulet.com
Employees(FY) 2600
ISIN US45784P1012

Performance

-3.1%

+12.68%

+36.07%

+42.35%

+22.86%

YTD

+47.07%

Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Advanced Technical Analysis

Technical Analysis of PODD 2024-11-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 96, indicating robust upward momentum, while the Technical Score of 76 further supports this positive outlook. However, the Oscillators Score of 56 suggests a neutral stance, indicating potential consolidation or a pause in the upward trend, which investors should monit...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of PODD

Stock Rank

Recent News & Updates

2024-11-20 19:30
Insulet Announces Omnipod 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S.(Businesswire)
2024-11-20 08:30
Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.(Business Wire)
2024-11-20 05:11
Baptista Downgrades Insulet to Underperform(MT Newswires)
2024-11-16 07:27
Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals(Simply Wall St.)
2024-11-15 06:00
Insulet to Present at Upcoming Investor Conferences(Business Wire)
2024-11-14 17:00
Insulet to Present at Upcoming Investor Conferences(Businesswire)
2024-11-13 09:50
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick(Zacks)
2024-11-13 02:15
Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace(Zacks)
2024-11-12 19:00
PODD: Raising target price to $289.00(Argus Research)
2024-11-12 15:05
Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More(Zacks)
2024-11-12 09:45
Why Insulet (PODD) is a Top Growth Stock for the Long-Term(Zacks)
2024-11-12 08:10
PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up(Zacks)
2024-11-12 06:45
Insulet price target raised to $317 from $234 at Morgan Stanley(TipRanks)
2024-11-11 06:52
Barclays Adjusts Price Target on Insulet to $234 From $220, Maintains Equalweight Rating(MT Newswires)
2024-11-11 04:21
Insulet CEO on earnings, GLP-1 and election impact(Youtube)
2024-11-10 07:59
Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts(Simply Wall St.)
2024-11-09 07:50
Insulet Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
2024-11-09 00:40
Top Stock Movers Now: Axon Enterprise, Sweetgreen, Akamai Technologies, and More(Investopedia)
2024-11-08 22:58
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues(Yahoo Finance)
2024-11-08 17:01
Tandem, Insulet tout Type 2 expectations as tech attracts new users(Yahoo Finance)
2024-11-08 16:39
S&P 500 Gains and Losses Today: Axon Shares Surge as Taser Maker Tops Estimates(Investopedia)
2024-11-08 12:55
Costco Stock Breaks Out Past Buy Point, Reaches All-Time High(Investor's Business Daily)
2024-11-08 12:53
Wolfe Research Adjusts Price Target on Insulet to $265 From $220(MT Newswires)
2024-11-08 12:50
Leerink Partners Adjusts Price Target on Insulet to $278 From $262(MT Newswires)
2024-11-08 12:50
Jefferies Raises Price Target on Insulet to $300 From $260(MT Newswires)
2024-11-08 12:49
BTIG Raises Price Target on Insulet to $270 From $260(MT Newswires)
2024-11-08 12:48
Bernstein Adjusts Price Target on Insulet to $305 From $300(MT Newswires)
2024-11-08 12:46
Stifel Adjusts Price Target on Insulet to $245 From $185(MT Newswires)
2024-11-08 12:45
JPMorgan Adjusts Price Target on Insulet to $280 From $250(MT Newswires)
2024-11-08 03:39
S&P 500 Gains and Losses Today: Axon Shares Surge as Taser Maker Tops Estimates(Investopedia)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.